Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 2,863,100 | 2,664,900 | 2,741,700 | 2,751,800 | 2,841,100 |
| Cost of Goods | 967,700 | 872,900 | 907,000 | 867,800 | 924,500 |
| Gross Profit | 1,895,400 | 1,792,000 | 1,834,700 | 1,884,000 | 1,916,600 |
| Operating Expenses | 1,454,400 | 1,323,600 | 1,026,500 | 1,402,200 | 1,452,600 |
| Operating Income | 441,000 | 468,400 | 808,200 | 481,800 | 464,000 |
| Other Income | -50,200 | -34,800 | -607,100 | -51,800 | -47,100 |
| Pre-tax Income | 390,800 | 433,600 | 201,100 | 430,000 | 416,900 |
| Income Tax | 84,800 | 106,100 | -80,400 | 87,400 | 100,800 |
| Net Income Continuous | 306,000 | 327,400 | 281,500 | 342,500 | 316,100 |
| Minority Interests | -2,700 | -2,200 | -900 | -3,000 | -100 |
| Net Income | $303,300 | $325,200 | $280,600 | $339,600 | $316,000 |
| EPS Basic Total Ops | 0.70 | 0.75 | 0.65 | 0.78 | 0.73 |
| EPS Basic Continuous Ops | 0.70 | 0.75 | 0.65 | 0.78 | 0.73 |
| EPS Diluted Total Ops | 0.70 | 0.75 | 0.65 | 0.78 | 0.73 |
| EPS Diluted Continuous Ops | 0.70 | 0.75 | 0.65 | 0.78 | 0.73 |
| EBITDA(a) | $767,000 | $770,300 | $752,900 | $796,500 | $791,700 |